SMI# 9
CAS : 1002789-86-7
Ref. 3D-CQB78986
| 5mg | À demander | ||
| 10mg | À demander | ||
| 25mg | À demander | ||
| 50mg | À demander | ||
| 100mg | À demander |
Informations sur le produit
SMI# 9 is a benzoate that inhibits the proliferation of cancer cells by binding to PD-L1, which is a protein expressed in many types of cancer cells. SMI# 9 also has anticancer activity against breast and prostate cancers, as well as melanoma. The compound was shown to have predictive biomarker properties in an assay with human breast tumor tissue samples, which may be due to the inhibition of the expression of mcf-7. SMI# 9 binds to the triazine site on pd-l1, which prevents it from binding to its receptor and blocks the activation of immune cells. This drug has been tested in clinical trials for safety and efficacy in patients with advanced solid tumors and is currently undergoing Phase III clinical trials.
Propriétés chimiques
Question d’ordre technique sur : 3D-CQB78986 SMI# 9
Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages
